Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Healthcare AI newswatch: FDA’s AI gambit, FDA’s blind spot, everybody’s agentic AI, more
The FDA is getting AI-aggressive about speeding up device reviews. Its plan is to unleash generative AI on tedious and repetitive tasks.
Private equity firm Deerfield earmarks $600M for healthcare investments
Deerfield Management released details on its latest Healthcare Innovations Fund program, promising to finance “promising therapeutics” and “elevating emerging technologies," including artificial intelligence.
UnitedHealth sued by shareholders over concealing fallout of Thompson's murder
In a lawsuit, plaintiffs allege the company changed course from a long-standing policy of denying medical claims, hiding from investors its impact on profits. The insurer denies any wrongdoing and vowed to defend itself in court.
Most of U.S. supply of iodine contrast may soon be subject to 25% tariffs
If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S.
Report: Former TV writer exploiting ACA to sell bare-bones insurance plans
Bloomberg writes about a company, Quick Health, run by a former comedy writer, who through a loophole in the law is accused of "hiring" members for fake jobs to enroll them in junk insurance policies.

FDA taking the long view of generative AI in healthcare

The FDA’s fledgling Digital Health Advisory Committee (DHAC) only held its first meeting last week, but it has already committed its thinking to writing.

healthcare insurance fraud scam scheme legal lawsuit

Texas clinics face potential $300M fine for submitting 20K false claims

A jury found Healthcare Associates of Texas guilty of knowingly submitting tens of thousands of fraudulent claims to Medicare, costing the government more than $2.8 million.

Report: 44% of adults in the U.S. are uninsured or underinsured

According to an analysis from the Commonwealth Fund, millions of patients are skipping necessary care and struggling to pay mounting medical debt.

Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.

Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

artificial intelligence AI in healthcare

Industry Watcher’s Digest

An influential industry group, AdvaMed, really likes President-Elect Trump’s choice of Dr. Oz for CMS administrator.

5 ways to let AI raise patient satisfaction, elevate provider performance

It’s been years since AI proponents started promising big returns on healthcare providers’ investments in the technology. The results have yet to catch up with the pitches. What’s the holdup?

Industry Watcher’s Digest

Black-box outputs aren’t just a problem with AI. They’re also a problem with physicians.

artificial intelligence AI life sciences biopharma

When life sciences met artificial intelligence

The pace of AI adoption is quickening in the sector, which includes biopharmaceuticals, digital health, clinical diagnostics and medical devices.

Business Intelligence

Healthcare AI newswatch: FDA’s AI gambit, FDA’s blind spot, everybody’s agentic AI, more

Private equity firm Deerfield earmarks $600M for healthcare investments

UnitedHealth sued by shareholders over concealing fallout of Thompson's murder

Most of U.S. supply of iodine contrast may soon be subject to 25% tariffs

Report: Former TV writer exploiting ACA to sell bare-bones insurance plans